Literature DB >> 33917549

Association of Bovine Leukemia Virus-Induced Lymphoma with BoLA-DRB3 Polymorphisms at DNA, Amino Acid, and Binding Pocket Property Levels.

Chieh-Wen Lo1,2, Shin-Nosuke Takeshima3,4, Kosuke Okada5, Etsuko Saitou6, Tatsuo Fujita7, Yasunobu Matsumoto1,2, Satoshi Wada8, Hidetoshi Inoko9, Yoko Aida1,2,3,10.   

Abstract

Bovine leukemia virus (BLV) causes enzootic bovine leucosis, a malignant B-cell lymphoma in cattle. The DNA sequence polymorphisms of bovine leukocyte antigen (BoLA)-DRB3 have exhibited a correlation with BLV-induced lymphoma in Holstein cows. However, the association may vary between different cattle breeds. Furthermore, little is known about the relationship between BLV-induced lymphoma and DRB3 at the amino acid and structural diversity levels. Here, we comprehensively analyzed the correlation between BLV-induced lymphoma and DRB3 at DNA, amino acid, and binding pocket property levels, using 106 BLV-infected asymptomatic and 227 BLV-induced lymphoma Japanese black cattle samples. DRB3*011:01 was identified as a resistance allele, whereas DRB3*005:02 and DRB3*016:01 were susceptibility alleles. Amino acid association studies showed that positions 9, 11, 13, 26, 30, 47, 57, 70, 71, 74, 78, and 86 were associated with lymphoma susceptibility. Structure and electrostatic charge modeling further indicated that binding pocket 9 of resistance DRB3 was positively charged. In contrast, alleles susceptible to lymphoma were neutrally charged. Altogether, this is the first association study of BoLA-DRB3 polymorphisms with BLV-induced lymphoma in Japanese black cattle. In addition, our results further contribute to understanding the mechanisms regarding how BoLA-DRB3 polymorphisms mediate susceptibility to BLV-induced lymphoma.

Entities:  

Keywords:  BoLA-DRB3; amino acid motif; antigen recognition sites; association study; bovine leukemia virus; electrostatic charge; lymphoma; peptide-binding pockets; polymorphisms

Year:  2021        PMID: 33917549     DOI: 10.3390/pathogens10040437

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  6 in total

1.  Enzootic bovine leukosis in a 21-month-old Japanese Black cow with high susceptibility.

Authors:  Masaki Maezawa; Kana Sakaguchi; Yuka Tagaino; Yuki Fujii; Masataka Akagami; Junko Kawakami; Ken-Ichi Watanabe; Yoshiyasu Kobayashi; Haruko Ogawa; Hisashi Inokuma
Journal:  J Vet Diagn Invest       Date:  2022-06-10       Impact factor: 1.569

2.  Comprehensive Comparison of Novel Bovine Leukemia Virus (BLV) Integration Sites between B-Cell Lymphoma Lines BLSC-KU1 and BLSC-KU17 Using the Viral DNA Capture High-Throughput Sequencing Method.

Authors:  Meripet Polat Yamanaka; Susumu Saito; Kazuyoshi Hosomichi; Yoko Aida
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

3.  BoLA-DRB3 Polymorphism Controls Proviral Load and Infectivity of Bovine Leukemia Virus (BLV) in Milk.

Authors:  Ayumi Nakatsuchi; Sonoko Watanuki; Liushiqi Borjigin; Hirotaka Sato; Lanlan Bai; Ryosuke Matsuura; Maho Kuroda; Hironobu Murakami; Reiichiro Sato; Sakurako Asaji; Asako Ando; Yasunobu Matsumoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Pathogens       Date:  2022-02-05

4.  Molecular Characterization of Bovine Leukemia Virus with the Evidence of a New Genotype Circulating in Cattle from Kazakhstan.

Authors:  Akhmetzhan Sultanov; Marzena Rola-Łuszczak; Saltanat Mamanova; Anna Ryło; Zbigniew Osiński; Meruyert A Saduakassova; Elvira Bashenova; Jacek Kuźmak
Journal:  Pathogens       Date:  2022-01-28

5.  Single-Nucleotide Polymorphism on Spermatogenesis Associated 16 Gene-Coding Region Affecting Bovine Leukemia Virus Proviral Load.

Authors:  Hirohisa Mekata; Mari Yamamoto
Journal:  Vet Sci       Date:  2022-06-06

6.  A pooled testing system to rapidly identify cattle carrying the elite controller BoLA-DRB3*009:02 haplotype against bovine leukemia virus infection.

Authors:  Kosuke Notsu; Hala El Daous; Shuya Mitoma; Junzo Norimine; Satoshi Sekiguchi
Journal:  HLA       Date:  2021-12-19       Impact factor: 8.762

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.